<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR50">
 <label>50</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lodi</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Phillips</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Touloumi</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Geskus</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Meyer</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Thiébaut</surname>
    <given-names>R</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds ¡200, ¡350, and ¡500 cells/mm
   <sup>3</sup>: assessment of need following changes in treatment guidelines
  </article-title>
  <source>Clin Infect Dis</source>
  <year>2011</year>
  <volume>53</volume>
  <issue>8</issue>
  <fpage>817</fpage>
  <lpage>825</lpage>
  <pub-id pub-id-type="doi">10.1093/cid/cir494</pub-id>
  <?supplied-pmid 21921225?>
  <pub-id pub-id-type="pmid">21921225</pub-id>
 </element-citation>
</ref>
